Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelics Research
Recent news which mentions Psychedelics Research
Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences
April 29, 2024
Tickers
NEWS
Tags
Psychedelics Education
Psychedelics Research
Psychedelics
From
Benzinga
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
April 17, 2024
Tickers
AWKNF
BETRF
CMND
FLHLF
Tags
MNMD
Biotech
HUGE
From
Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Tickers
AGNPF
ATAI
CMND
CMPS
Tags
AGNPF
Kanna
Cannabis
From
Benzinga
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
April 15, 2024
Tickers
NEWS
NUMIF
Tags
NUMIF
Earnings
News
From
Benzinga
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
April 09, 2024
Tickers
NEWS
OPTHF
Tags
Psychedelics
Benzinga
Psilocybin program
From
Benzinga
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
April 05, 2024
Tags
Benzinga
Psychedelics
FDA
From
Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
April 03, 2024
Tickers
AGNPF
Tags
DMT/Assisted Therapy
Human Stroke
Management
From
Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
March 30, 2024
Tickers
CMND
CMPS
CYBN
FLHLF
Tags
Market News
Cannabis
CMND
From
Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
March 29, 2024
Tickers
ATAI
CMND
CMPS
DRUG
Tags
LSDI
Cannabis
ATAI
From
Benzinga
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
March 29, 2024
Tickers
ATAI
CMPS
Tags
financial results
ATAI
Earnings
From
Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
March 28, 2024
Tickers
ATAI
NEWS
Tags
ATAI
News
treatment/resistant depression
From
Benzinga
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
March 27, 2024
Tickers
MDXXF
Tags
MDXX class molecules
Biotech
MDMA treatment
From
Benzinga
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
March 26, 2024
Tickers
MDXXF
NEWS
NUMIF
OPTHF
Tags
Biotech
Tel Aviv University
Benzinga
From
Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
March 25, 2024
Tickers
NEWS
NUMIF
Tags
psilocybin therapy
Psychedelics Research
MDMA Therapy
From
Benzinga
Congress Discusses Remaining FY2024 Spending Bill With Provisions On Cannabis Sales And Psychedelic Clinical Trials
March 22, 2024
Tags
Psychedelics
B/C/ cannabis
Benzinga
From
Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
TRUFF
Breakthrough Therapy Drug
PSIL
From
Benzinga
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
March 16, 2024
Tickers
ATAI
BETRF
CMND
ENVB
Tags
Psychedelics Reform
Management
Psychedelics Research
From
Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
SPRC
Psychedelics
FDA
From
Benzinga
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
March 01, 2024
Tickers
BRAXF
FLHLF
OPTHF
SILFF
Tags
Global
Market News
OPTHF
From
Benzinga
Beckley Academy's Open-Source Psychedelic Therapy Learning Framework Is Out: What's It All About? Authoring Team Shares Insights
February 29, 2024
Tags
Management
Education
Cannabis
From
Benzinga
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
February 28, 2024
Tickers
IXHL
NEWS
Tags
Psychedelics Research
IXHL
Management
From
Benzinga
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
January 31, 2024
Tickers
JNJ
MNMD
Tags
Reagan/Udall Foundation for the FDA
Psychedelic/Assisted Therapy Psychedelics regulation
Market News
From
Benzinga
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
January 26, 2024
Tickers
AWKNF
CMND
CMPS
FLHLF
Tags
Management
MDXXF
Financing
From
Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Benzinga
Psychedelics
CYBN
From
Benzinga
DEA Acknowledges Psychedelics & Cannabis Research Needs, Seeks Production Increases
November 01, 2023
Tags
News
Drug Enforcement Administration
Delta/9 THC
From
Benzinga
Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents
October 26, 2023
Tickers
CYBN
DMTTF
Tags
Legal
Psychedelics Research
Management
From
Benzinga
Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
October 23, 2023
Tickers
CYBN
DMTTF
Tags
Benzinga
Psychedelics
DMT Clinical Trial
From
Benzinga
Harvard's New Psychedelics Research Program Backed By Former Tesla Director's $16M Donation
October 18, 2023
Tickers
NFLX
TSLA
Tags
Psychedelics Research
Elon Musk
Antonio Gracias
From
Benzinga
Esteemed Psychedelic Researcher And Pioneer Roland Griffiths Passes Away At Age 77
October 18, 2023
Tags
Dr/ Roland Griffiths
General
Markets
From
Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
Tags
NUMIF
News
Guidance
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.